Korsana Biosciences, Inc.
Public company- Headquarters
- WALTHAM, Massachusetts
- Ticker
- KRSA
- CIK
- 0001755237
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| directorErrol B. De Souza, Ph.D. | Sep 11, 2026 | Departed |
| CFORhonda M. Chicko | Sep 11, 2026 | Departed |
| CEOJonathan Violin, Ph.D. | Sep 11, 2026 | Appointed |
| CMOMatthew Leoni, M.D. | Sep 11, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive departure
director departs: Errol B. De Souza, Ph.D.
Errol B. De Souza, Ph.D., director of Korsana Biosciences, Inc., resigns the role, effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: director
- Executive departure
director departs: Regina M. Graul, Ph.D.
Regina M. Graul, Ph.D., director of Korsana Biosciences, Inc., resigns the role, effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: director
- Executive departure
director departs: Peter M. Hecht, Ph.D.
Peter M. Hecht, Ph.D., director of Korsana Biosciences, Inc., resigns the role, effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: director
- Executive departure
director departs: Michael Higgins
Michael Higgins, director of Korsana Biosciences, Inc., resigns the role, effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: director
- Executive departure
director departs: Steven E. Hyman, M.D.
Steven E. Hyman, M.D., director of Korsana Biosciences, Inc., resigns the role, effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: director
- Executive departure
director departs: Dina Katabi, Ph.D.
Dina Katabi, Ph.D., director of Korsana Biosciences, Inc., resigns the role, effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: director
- Executive departure
CFO departs: Rhonda M. Chicko
Rhonda M. Chicko, Chief Financial Officer of Korsana Biosciences, Inc., resigns the role, effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: Chief Financial Officer
- Executive appointment
CEO appointed: Jonathan Violin, Ph.D.
Jonathan Violin, Ph.D. was named Chief Executive Officer and President of Korsana Biosciences, Inc., effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 11, 2026Role: Chief Executive Officer and President
Last verified Nov 8, 2026